Northern Trust’s Monopar Therapeutics MNPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14M | Buy |
31,813
+22,652
| +247% | +$810K | ﹤0.01% | 3312 |
|
|
2025
Q1 | $334K | Buy |
+9,161
| New | +$334K | ﹤0.01% | 3747 |
|
|
2023
Q2 | – | Sell |
-7,410
| Closed | -$51.5K | – | 4574 |
|
|
2023
Q1 | $51.5K | Buy |
7,410
+194
| +3% | +$1.35K | ﹤0.01% | 4261 |
|
|
2022
Q4 | $85.5K | Sell |
7,216
-59
| -0.8% | -$699 | ﹤0.01% | 4144 |
|
|
2022
Q3 | $55K | Buy |
7,275
+234
| +3% | +$1.77K | ﹤0.01% | 4298 |
|
|
2022
Q2 | $81K | Hold |
7,041
| – | – | ﹤0.01% | 4251 |
|
|
2022
Q1 | $90K | Sell |
7,041
-143
| -2% | -$1.83K | ﹤0.01% | 4383 |
|
|
2021
Q4 | $115K | Sell |
7,184
-84
| -1% | -$1.35K | ﹤0.01% | 4379 |
|
|
2021
Q3 | $177K | Buy |
7,268
+47
| +0.7% | +$1.15K | ﹤0.01% | 4228 |
|
|
2021
Q2 | $213K | Buy |
7,221
+21
| +0.3% | +$619 | ﹤0.01% | 4142 |
|
|
2021
Q1 | $223K | Sell |
7,200
-4,559
| -39% | -$141K | ﹤0.01% | 4077 |
|
|
2020
Q4 | $360K | Sell |
11,759
-1,191
| -9% | -$36.5K | ﹤0.01% | 3809 |
|
|
2020
Q3 | $347K | Buy |
12,950
+2,999
| +30% | +$80.4K | ﹤0.01% | 3680 |
|
|
2020
Q2 | $372K | Buy |
+9,951
| New | +$372K | ﹤0.01% | 3618 |
|